{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T12:05:23Z","timestamp":1790251523020,"version":"4.1.0"},"reference-count":48,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T00:00:00Z","timestamp":1790208000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>GNA15 is a G\u03b1q-family G protein whose physiological expression is largely restricted to hematopoietic cells. Nevertheless, aberrant upregulation has been reported in six histologically distinct malignancies, with elevated expression consistently associated with adverse clinical outcomes. Unlike the ubiquitously expressed G\u03b1q and G\u03b111 paralogs, GNA15 exhibits an expanded receptor-coupling repertoire that extends beyond their canonical GPCR interactions. Despite the diversity of tumor types, its oncogenic functions consistently converge on four major signaling programs: MAPK activation, BTK-dependent signaling, AMPK-mediated metabolic reprogramming, and EMT-associated cellular plasticity. Each of these mechanisms has been functionally validated in at least one cancer model. Across multiple malignancies, elevated GNA15 expression is associated with increased M2 macrophage infiltration, immunosuppressive transcriptional signatures, and poor patient outcomes. These associations remain correlative, however, as no study has yet demonstrated that GNA15 signaling directly drives these immune-related phenotypes. Nevertheless, existing evidence suggests that GNA15-associated changes in the tumor microenvironment could influence the effectiveness of immune checkpoint blockade and may also bear on the success of newer approaches such as engineered cellular therapies, bispecific antibodies, and antibody\u2013drug conjugates. By contrast, the evidence supporting its oncogenic function is considerably more robust: genetic silencing of GNA15 consistently attenuates malignant phenotypes across four independent tumor models, providing the strongest evidence for its therapeutic relevance. Its proposed immunological role, by comparison, remains hypothesis-generating, as it is derived exclusively from correlative observations and has not been evaluated in immune-competent experimental systems. Overall, GNA15 represents a biologically plausible yet clinically unvalidated link between GPCR signaling and tumor\u2013immune regulation. At present, the available evidence supports its development as a prognostic biomarker; whether it also has predictive value for immunotherapy response remains untested and requires prospective validation.<\/jats:p>","DOI":"10.3389\/fimmu.2026.1955711","type":"journal-article","created":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T11:18:47Z","timestamp":1790248727000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["GNA15 as a regulator of tumor\u2013immune crosstalk: oncogenic signaling, microenvironmental remodeling, and implications for targeted immunotherapy"],"prefix":"10.3389","volume":"17","author":[{"given":"Aarka","family":"Undar","sequence":"first","affiliation":[{"name":"Department of Bio-Medical Sciences, School of Bio Sciences & Technology, Vellore Institute of Technology","place":["Vellore, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shweta","family":"Sunil Nambiar","sequence":"additional","affiliation":[{"name":"Department of Bio-Medical Sciences, School of Bio Sciences & Technology, Vellore Institute of Technology","place":["Vellore, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mukil","family":"Srivasan","sequence":"additional","affiliation":[{"name":"Department of Bio-Medical Sciences, School of Bio Sciences & Technology, Vellore Institute of Technology","place":["Vellore, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abilash","family":"Valsala Gopalakrishnan","sequence":"additional","affiliation":[{"name":"Department of Bio-Medical Sciences, School of Bio Sciences & Technology, Vellore Institute of Technology","place":["Vellore, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabina","family":"Evan Prince","sequence":"additional","affiliation":[{"name":"Department of Biotechnology, School of Bio Sciences & Technology, Vellore Institute of Technology","place":["Vellore, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wuling","family":"Liu","sequence":"additional","affiliation":[{"name":"State Key Laboratory for Functions and Applications of Medicinal Plants, Guizhou Medical University","place":["Guiyang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaacov","family":"Ben-David","sequence":"additional","affiliation":[{"name":"State Key Laboratory for Functions and Applications of Medicinal Plants, Guizhou Medical University","place":["Guiyang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Babu","family":"Gajendran","sequence":"additional","affiliation":[{"name":"Department of Bio-Medical Sciences, School of Bio Sciences & Technology, Vellore Institute of Technology","place":["Vellore, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,24]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.70375","article-title":"G protein-coupled receptor signaling: implications and therapeutic development advances in cancers","volume":"6","author":"Khan","year":"2025","journal-title":"MedComm"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-physiol-030212-183750","article-title":"Mammalian phospholipase C","volume":"75","author":"Kadamur","year":"2013","journal-title":"Annu Rev Physiol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14133066","article-title":"GNAQ and GNA11 genes: a comprehensive review on oncogenesis, prognosis and therapeutic opportunities in uveal melanoma","volume":"14","author":"Silva-Rodr\u00edguez","year":"2022","journal-title":"Cancers (Basel)"},{"key":"B4","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1038\/nrc2069","article-title":"G-protein-coupled receptors and cancer","volume":"7","author":"Dorsam","year":"2007","journal-title":"Nat Rev Cancer"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-023-01529-7","article-title":"The GPCR-G\u03b1s-PKA signaling axis promotes T cell dysfunction and cancer immunotherapy failure","volume":"24","author":"Wu","year":"2023","journal-title":"Nat Immunol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202400458r","article-title":"G protein-coupled receptor-mediated signaling of immunomodulation in tumor progression","volume":"38","author":"Qiu","year":"2024","journal-title":"FASEB J"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1152\/ajpcell.00151.2022","article-title":"Physiology of chemokines in the cancer microenvironment","volume":"324","author":"Drouillard","year":"2023","journal-title":"Am J Physiol Cell Physiol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"14922","DOI":"10.1038\/s41598-021-94150-3","article-title":"G\u03b115 in early onset of pancreatic ductal adenocarcinoma","volume":"11","author":"Innamorati","year":"2021","journal-title":"Sci Rep"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1512086","article-title":"GNA15 predicts poor outcomes as a novel biomarker related to M2 macrophage infiltration in ovarian cancer","volume":"16","author":"Liu","year":"2025","journal-title":"Front Immunol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1186\/s13048-024-01419-y","article-title":"A novel defined programmed cell death related gene signature for predicting the prognosis of serous ovarian cancer","volume":"17","author":"Zhan","year":"2024","journal-title":"J Ovarian Res"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21456","article-title":"Ovarian cancer statistics, 2018","volume":"68","author":"Torre","year":"2018","journal-title":"CA Cancer J Clin"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.14670\/hh-18-714","article-title":"GNA15 facilitates the Malignant development of thyroid carcinoma cells via the BTK-mediated MAPK signaling pathway","volume":"39","author":"Sun","year":"2024","journal-title":"Histol Histopathol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.724435","article-title":"Downregulation of GNA15 inhibits cell proliferation via p38 MAPK pathway and correlates with prognosis of adult acute myeloid leukemia with normal karyotype","volume":"11","author":"Li","year":"2021","journal-title":"Front Oncol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1659183","article-title":"Multiomics profiling identifies the poor prognostic role of a tumor cluster with GNA15 overexpression in triple-negative breast cancer","volume":"16","author":"Wang","year":"2025","journal-title":"Front Immunol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1007\/s11010-024-05198-4","article-title":"GNA15 induces drug resistance in B cell acute lymphoblastic leukemia by promoting fatty acid oxidation via activation of the AMPK pathway","volume":"480","author":"Luo","year":"2025","journal-title":"Mol Cell Biochem"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.88.22.10049","article-title":"Characterization of G-protein alpha subunits in the Gq class: expression in murine tissues and in stromal and hematopoietic cell lines","volume":"88","author":"Wilkie","year":"1991","journal-title":"Proc Natl Acad Sci USA"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1007\/978-94-007-6724-9_15-1","article-title":"Identification of a stretch of six divergent amino acids on the \u03b15 helix of G\u03b116 as a major determinant of the promiscuity and efficiency of receptor coupling","volume":"380","author":"Ho","year":"2004","journal-title":"Biochem J"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1042\/ebc20240011","article-title":"CaMKK2: bridging the gap between Ca\u00b2+ signalling and energy-sensing","volume":"68","author":"McAloon","year":"2024","journal-title":"Essays Biochem"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1021\/acsptsci.3c00214","article-title":"Recommended tool compounds: application of YM-254890 and FR900359 to interrogate G\u03b1q\/11-mediated signaling pathways","volume":"6","author":"Voss","year":"2023","journal-title":"ACS Pharmacol Transl Sci"},{"key":"B20","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.blre.2019.04.005","article-title":"Epidemiology of acute myeloid leukemia: recent progress and enduring challenges","volume":"36","author":"Shallis","year":"2019","journal-title":"Blood Rev"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.26822","article-title":"Acute myeloid leukemia: 2023 update on diagnosis, risk-stratification, and management","volume":"98","author":"Shimony","year":"2023","journal-title":"Am J Hematol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1159\/000536152","article-title":"Pathophysiology of acute myeloid leukemia","volume":"147","author":"Wachter","year":"2024","journal-title":"Acta Haematol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2023.26348","article-title":"Thyroid cancer: A review","volume":"331","author":"Boucai","year":"2024","journal-title":"JAMA"},{"key":"B24","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1038\/s41571-021-00565-2","article-title":"Treatment landscape of triple-negative breast cancer expanded options, evolving needs","volume":"19","author":"Bianchini","year":"2022","journal-title":"Nat Rev Clin Oncol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.975197","article-title":"The functional role of p38 MAPK pathway in Malignant brain tumors","volume":"13","author":"Grave","year":"2022","journal-title":"Front Pharmacol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1038\/s41417-023-00622-1","article-title":"p38 kinase in gastrointestinal cancers","volume":"30","author":"Phan","year":"2023","journal-title":"Cancer Gene Ther"},{"key":"B27","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s12943-018-0779-z","article-title":"Role of Bruton's tyrosine kinase in B cells and Malignancies","volume":"17","author":"Pal Singh","year":"2018","journal-title":"Mol Cancer"},{"key":"B28","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s40164-022-00315-9","article-title":"Bruton tyrosine kinase inhibitors in B-cell lymphoma: beyond the antitumor effect","volume":"11","author":"Wang","year":"2022","journal-title":"Exp Hematol Oncol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1080\/10409238.2020.1727840","article-title":"Spatial control of AMPK signaling at subcellular compartments","volume":"55","author":"Chauhan","year":"2020","journal-title":"Crit Rev Biochem Mol Biol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2024.115183","article-title":"Deletion of AMP-activated protein kinase impairs metastasis and is rescued by ROS scavenging or ectopic CD36 expression","volume":"44","author":"Ramakrishnan","year":"2025","journal-title":"Cell Rep"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.cd-21-0316","article-title":"Spatiotemporal immune landscape of colorectal cancer liver metastasis at single-cell level","volume":"12","author":"Wu","year":"2022","journal-title":"Cancer Discov"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexcr.2020.112315","article-title":"Tumor-associated macrophages induce PD-L1 expression in gastric cancer cells through IL-6 and TNF-\u03b1 signaling","volume":"396","author":"Ju","year":"2020","journal-title":"Exp Cell Res"},{"key":"B33","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1007\/s10495-026-02351-w","article-title":"Cholesterol as a metabolic integrator of oncogenic signaling, immune evasion, and therapy resistance","volume":"31","author":"Skossyrskiy","year":"2026","journal-title":"Apoptosis"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2024.113930","article-title":"Targeting the tumor immune microenvironment: GPCRs as key regulators in triple-negative breast cancer","volume":"147","author":"Wang","year":"2025","journal-title":"Int Immunopharmacol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"4388","DOI":"10.1038\/s41467-024-48700-8","article-title":"Single-cell and spatial transcriptomics analysis of non-small cell lung cancer","volume":"15","author":"De Zuani","year":"2024","journal-title":"Nat Commun"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdv615","article-title":"Regulation of PD-L1: a novel role of pro-survival signalling in cancer","volume":"27","author":"Chen","year":"2016","journal-title":"Ann Oncol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.3390\/ijms222212297","article-title":"What do we have to know about PD-L1 expression in prostate cancer? A systematic literature review. Part 4: Experimental treatments in pre-clinical studies","volume":"22","author":"Palicelli","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.4c02354","article-title":"Small molecule modulators of AMP-activated protein kinase (AMPK) activity and their potential in cancer therapy","volume":"68","author":"Strang","year":"2025","journal-title":"J Med Chem"},{"key":"B39","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1016\/j.molcel.2017.05.032","article-title":"AMPK: mechanisms of cellular energy sensing and restoration of metabolic balance","volume":"66","author":"Garcia","year":"2017","journal-title":"Mol Cell"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11206139","article-title":"Bruton's tyrosine kinase inhibitors: the next frontier of B-cell-targeted therapies for cancer, autoimmune disorders, and multiple sclerosis","volume":"11","author":"Garg","year":"2022","journal-title":"J Clin Med"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1101\/2024.10.11.24315056","article-title":"Practical management of adverse events in patients receiving tarlatamab, a DLL3-targeted bispecific T-cell engager immunotherapy","volume":"131","author":"Sands","year":"2025","journal-title":"Cancer"},{"key":"B42","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s40364-021-00294-9","article-title":"The immune context of bispecific T cell engager in cancer treatment","volume":"9","author":"Zhou","year":"2021","journal-title":"biomark Res"},{"key":"B43","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s12943-023-01723-z","article-title":"CAR-cell therapy in the era of solid tumor treatment: current challenges and emerging therapeutic advances","volume":"22","author":"Maalej","year":"2023","journal-title":"Mol Cancer"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1038\/s41571-021-00470-8","article-title":"Unlocking the potential of antibody-drug conjugates for cancer therapy","volume":"18","author":"Drago","year":"2021","journal-title":"Nat Rev Clin Oncol"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2020.102975","article-title":"CAR-NK cells: a promising cellular immunotherapy for cancer","volume":"59","author":"Xie","year":"2020","journal-title":"EBioMedicine"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.3390\/cells13050451","article-title":"Building a better defense: expanding and improving natural killer cells for adoptive cell therapy","volume":"13","author":"Maia","year":"2024","journal-title":"Cells"},{"key":"B47","doi-asserted-by":"publisher","first-page":"4114","DOI":"10.1038\/s41467-025-59362-5","article-title":"Identification of leukemia-enriched signature through the development of a comprehensive pediatric single-cell atlas","volume":"16","author":"Mumme","year":"2025","journal-title":"Nat Commun"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1606125","article-title":"Unraveling the role of GPCR signaling in metabolic reprogramming and immune microenvironment of lung adenocarcinoma: a multi-omics study with experimental validation","volume":"16","author":"Wang","year":"2025","journal-title":"Front Immunol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1955711\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T11:18:49Z","timestamp":1790248729000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1955711\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,24]]},"references-count":48,"alternative-id":["10.3389\/fimmu.2026.1955711"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1955711","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,24]]},"article-number":"1955711"}}